Published Research Summaries (click "Search" in Menu to filter)

CBD Helps with Inflammation in Cocaine Use Disorder Patients

This was a single-site randomized controlled trial published in the journal Neuropsychopharmacology in July 2021. It used blood samples to determine if CBD helped reduce inflammation markers in Cocaine Use Disorder (CUD) patients.

Study: 84% of Patients Reduced or Eliminated Prescription Drugs with Cannabis

This study was published in the Harm Reduction Journal in July 2021. It focused on learning more about patients that substituted prescription drugs with cannabis, the type of drugs substituted, and the effect on prescription drug use.

Study: Arthritis Symptom Relief Reported by the Majority of Cannabis Users

This study was published in the journal Arthritis Care & Research in July 2021, a publication of the American College of Rheumatology. It examined patient input from 2014 and 2019 about their use of cannabis-based products.

THC + CBD Works Better for Anxiety

This study was conducted on mice and is scheduled to be published September 15th, 2021 in the journal Neuropharmacology and is available online in advance. It examined the effects of low and high doses of 1) D9-THC only and 2) D9-THC + CBD on male and female mice using a research standard "elevated-plus" maze.

Caryophyllene & Myrcene Dominant Cannabis Best for Migraine Headaches

Published in May 2018 in the Journal of Headache & Pain, this was an electronic survey of registered medicinal cannabis patients with headache, arthritis, and chronic pain. This paper focused on those patients with chronic headache pain.

THC/CBD/CBN Extract Improves Sleep for Insomnia Patients

This randomized, double-blind, placebo-controlled, crossover study was published in the journal Sleep in June 2021. Twenty-three participants were tracked over a period of two weeks.

CBD Helps with Moderate to Severe Pain, Anxiety, & Depression Symptoms, but Not Mild Symptoms

This observational study of 279 patients was published in the Journal of Cannabis Research in June 2021. It examined the effect of CBD-rich treatments on pain, anxiety, depression symptoms, and wellbeing.

Stage IV Cancer Patients Reduced Opioid Use with Cannabis

Results from a small Randomized Clinical Trial (RCT) were published in the journal, Supportive Care in Cancer in June 2021. The pilot study tracked patients with stage IV cancer requiring opioids in two groups over 3 months. One group was given medical cannabis, and one group was not.

Cannabis Smokers Have Lower Toxicant Exposure than Tobacco Smokers

Published online ahead of print in the journal Nicotine & Tobacco Research on June 12, 2021, this study examined 3 cohorts: tobacco-only users, cannabis-only users, and users of both tobacco and cannabis.

Study: Light Cannabis Use Actually Improves Decision-Making Skills

Published in the July-September 2021 edition of the journal Cognitive Development, this study assessed 804 adolescents at age 14 and 19.

Δ9-THC & Δ8-THC Help Reduce Oral Cancer Cell Growth & Proliferation

This study of cell cultures (in vitro) was published in June 2021 in the journal Archives of Oral Biology. It used both popular forms of THC, and both showed promising results for oral cancer cell inhibition and apoptosis (cell suicide).

Study: COPD Hospital Outcomes Better for Cannabis Users

This retrospective study on cannabis-using patients with COPD that were hospitalized between 2005 and 2014, was published in Cannabis and Cannabinoid Research in February 2021.

Opioid Use for Chronic Pain Drops in 42% of Canadian Medical Cannabis Patients

Published in the Canadian Journal of Anaesthesia in May 2021, this was a 12 month observational study that followed patients suffering from chronic pain and who were enrolled in the medical cannabis program in Canada.

Study: Cannabis Helps with Recurrent Pain, PTSD, Sleep & Quality of Life

Published May 20, 2021 in the journal Frontiers in Public Health, this study examined 214 patients new to the Canadian Medical Cannabis Program. The goal was to collect data on efficacy and safety, and what impact cannabis had on their quality of life (QOL) over a 6 week period.

Quality of Life Improves in Patients with High-Grade Glioma (Brain Tumors)

This Phase 2 randomized clinical trial was published in the journal Frontiers in Oncology in May 2021, and focused on the tolerability and side effects of cannabis extracts in patients with fast-growing tumors of the glial cells in the brain and spinal cord.

Epileptic Seizures in Children Dramatically Reduced

From a study published May 25, 2021 by Drug Science, the results showed that there was a 96% chance that a child with severe epilepsy would have a significant reduction in seizures with whole-plant cannabis medicine.

Medical Cannabis Helps Reduce Nicotine Use

Published May 13, 2021 in the Journal of Substance Abuse Treatment, this study examined 650 individuals who reported current or previous tobacco or nicotine use.

Topical Cannabis Helps Heal Difficult Wounds

Published May 19, 2021 in the journal Experimental Dermatology, this study assessed the effects of topical cannabis treatments in 14 elderly patients with recalcitrant leg ulcers.

1 … 14 15 16 17 18 … 21

ads:

WARNING: Everyone has unique biochemistry, preexisting conditions, and mental state. Almost all medicinal and psychotropic products can cause adverse side effects in some people. The same is true with cannabinoid products, especially when they contain psychotropic cannabinoids like THC. Be very careful. Reported or statistically implied adverse effects include, but are not limited to: cannabis hyperemesis syndrome (CHS), adverse cardiovascular events (stroke, heart attack), arrhythmia, psychosis, and addiction (cannabis use disorder, or CUD).

Your cart is currently empty.

Enable cookies to use the shopping cart

t: e

(-)

Item Quantity

Special instructions